SK282543B6 - Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe - Google Patents
Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe Download PDFInfo
- Publication number
- SK282543B6 SK282543B6 SK1359-95A SK135995A SK282543B6 SK 282543 B6 SK282543 B6 SK 282543B6 SK 135995 A SK135995 A SK 135995A SK 282543 B6 SK282543 B6 SK 282543B6
- Authority
- SK
- Slovakia
- Prior art keywords
- hcv
- epitopes
- polypeptides
- type
- epitope
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6040093A | 1993-05-10 | 1993-05-10 | |
PCT/US1994/005151 WO1994027153A1 (en) | 1993-05-10 | 1994-05-09 | Methods of typing hepatitis c virus and reagents for use therein |
Publications (2)
Publication Number | Publication Date |
---|---|
SK135995A3 SK135995A3 (en) | 1996-09-04 |
SK282543B6 true SK282543B6 (sk) | 2002-10-08 |
Family
ID=22029220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1359-95A SK282543B6 (sk) | 1993-05-10 | 1994-05-09 | Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe |
Country Status (19)
Country | Link |
---|---|
US (3) | US6054264A (pl) |
EP (1) | EP0698216B2 (pl) |
JP (1) | JP3645904B2 (pl) |
KR (1) | KR100330278B1 (pl) |
CN (1) | CN1129795C (pl) |
AT (1) | ATE281647T1 (pl) |
CZ (1) | CZ294629B6 (pl) |
DE (1) | DE69434117T3 (pl) |
DK (1) | DK0698216T4 (pl) |
ES (1) | ES2232815T5 (pl) |
GE (1) | GEP20012421B (pl) |
HU (1) | HU224513B1 (pl) |
PL (3) | PL175338B1 (pl) |
PT (1) | PT698216E (pl) |
RO (1) | RO115471B1 (pl) |
RU (1) | RU2158928C2 (pl) |
SK (1) | SK282543B6 (pl) |
UA (1) | UA46707C2 (pl) |
WO (1) | WO1994027153A1 (pl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU671967B2 (en) * | 1991-11-21 | 1996-09-19 | Common Services Agency | Hepatitis-C virus testing |
US7255997B1 (en) * | 1993-04-27 | 2007-08-14 | N.V. Innogenetics S.A. | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
ATE553201T1 (de) | 1993-04-27 | 2012-04-15 | Innogenetics Nv | Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel |
CZ294629B6 (cs) * | 1993-05-10 | 2005-02-16 | Chiron Corporation | Způsob klasifikace typů hepatitis C viru, polypeptid a kompozice pro použití ve způsobu |
US5882852A (en) * | 1993-06-29 | 1999-03-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates |
US7070790B1 (en) | 1993-06-29 | 2006-07-04 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
DE19504302A1 (de) * | 1995-02-09 | 1996-08-14 | Boehringer Mannheim Gmbh | Methode zur serologischen Typisierung mittels typspezifischer Antigene |
EP0829488A4 (en) * | 1995-04-28 | 1999-04-07 | Srl Inc | ANTIGENIC PEPTIDE COMPOUND AND IMMUNOLOGICAL ASSAY METHOD |
US6514731B1 (en) | 1996-05-24 | 2003-02-04 | Chiron Corporation | Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens |
US7052830B1 (en) * | 1998-06-09 | 2006-05-30 | Branch Andrea D | Hepatitis C virus peptides and uses thereof |
WO2000031130A1 (en) * | 1998-11-20 | 2000-06-02 | Bio Merieux | Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications |
US6995299B2 (en) * | 1999-11-02 | 2006-02-07 | University Of Connecticut | Propagation of human hepatocytes in non-human animals |
US8124348B2 (en) | 2000-08-23 | 2012-02-28 | Jonathan Zmuda | Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes |
US20030152942A1 (en) * | 2001-05-09 | 2003-08-14 | Lance Fors | Nucleic acid detection in pooled samples |
US7196183B2 (en) * | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
CA2481502A1 (en) * | 2002-04-04 | 2003-10-16 | Achillion Pharmaceuticals, Inc. | Hcv antiviral and cytotoxicity drug screening assay |
WO2005010035A2 (en) * | 2003-07-22 | 2005-02-03 | Branch Andrea D | Alternate reading frame polypeptides derived from hepatitis c and methods of their use |
EP1658302B1 (en) * | 2003-07-25 | 2010-08-25 | IDENIX Pharmaceuticals, Inc. | Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
ES2596753T3 (es) * | 2003-08-29 | 2017-01-11 | Fujirebio Europe N.V. | Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo |
JP5138230B2 (ja) | 2004-01-07 | 2013-02-06 | サード・ウェーブ・テクノロジーズ・インク | C型肝炎ウイルスの遺伝子型の決定方法 |
JP4533656B2 (ja) * | 2004-04-28 | 2010-09-01 | アボットジャパン株式会社 | 特異性の改良されたc型肝炎ウイルス(hcv)抗体測定法 |
US7858752B2 (en) * | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
CN110261616B (zh) * | 2019-04-30 | 2021-07-20 | 广东菲鹏生物有限公司 | 一种丙型肝炎病毒检测试剂盒 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
US5124246A (en) * | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
DE3886363T3 (de) * | 1987-11-18 | 2004-09-09 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | NANBV-Diagnostika |
HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
KR100206150B1 (ko) * | 1990-04-04 | 1999-07-01 | 로버트 피. 블랙버언 | 항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체 |
US6190864B1 (en) * | 1991-05-08 | 2001-02-20 | Chiron Corporation | HCV genomic sequences for diagnostics and therapeutics |
UA40572C2 (uk) * | 1991-06-24 | 2001-08-15 | Чірон Корпорейшн | Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти) |
DE69223562T2 (de) * | 1991-08-27 | 1998-06-04 | Hoffmann La Roche | Verfahren und Reagenzien zum Nachweis von Hepatitis C |
EP0532258A2 (en) * | 1991-09-09 | 1993-03-17 | Immuno Japan Inc. | Oligonucleotides and determination system of HCV genotypes |
CA2119013A1 (en) * | 1991-09-16 | 1993-04-01 | Richard R. Lesniewski | Hepatitis c assay |
AU671967B2 (en) * | 1991-11-21 | 1996-09-19 | Common Services Agency | Hepatitis-C virus testing |
EP1878797B1 (en) | 1992-07-16 | 2010-04-28 | Advanced Life Science Institute, Inc | Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same |
NZ257077A (en) * | 1992-11-06 | 1997-05-26 | Chiron Mimotopes Pty Ltd | Support for synthesis of modular polymers |
JP3751315B2 (ja) | 1993-05-05 | 2006-03-01 | コモン サーヴィシス エージェンシー | C型肝炎ウイルス4、5及び6型 |
CZ294629B6 (cs) * | 1993-05-10 | 2005-02-16 | Chiron Corporation | Způsob klasifikace typů hepatitis C viru, polypeptid a kompozice pro použití ve způsobu |
EP0729973A4 (en) * | 1993-10-29 | 1998-12-30 | Srl Inc | AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE |
-
1994
- 1994-05-09 CZ CZ19952929A patent/CZ294629B6/cs not_active IP Right Cessation
- 1994-05-09 GE GEAP19942944A patent/GEP20012421B/en unknown
- 1994-05-09 PL PL94323368A patent/PL175338B1/pl unknown
- 1994-05-09 UA UA95114832A patent/UA46707C2/uk unknown
- 1994-05-09 PL PL94323367A patent/PL175360B1/pl unknown
- 1994-05-09 EP EP94916061A patent/EP0698216B2/en not_active Expired - Lifetime
- 1994-05-09 KR KR1019950704993A patent/KR100330278B1/ko not_active IP Right Cessation
- 1994-05-09 HU HU9503219A patent/HU224513B1/hu active IP Right Grant
- 1994-05-09 ES ES94916061T patent/ES2232815T5/es not_active Expired - Lifetime
- 1994-05-09 SK SK1359-95A patent/SK282543B6/sk not_active IP Right Cessation
- 1994-05-09 RO RO95-01952A patent/RO115471B1/ro unknown
- 1994-05-09 DE DE69434117T patent/DE69434117T3/de not_active Expired - Lifetime
- 1994-05-09 PT PT94916061T patent/PT698216E/pt unknown
- 1994-05-09 PL PL94311653A patent/PL175342B1/pl unknown
- 1994-05-09 WO PCT/US1994/005151 patent/WO1994027153A1/en active IP Right Grant
- 1994-05-09 RU RU95122701/13A patent/RU2158928C2/ru active
- 1994-05-09 CN CN94192560A patent/CN1129795C/zh not_active Expired - Lifetime
- 1994-05-09 JP JP52562794A patent/JP3645904B2/ja not_active Expired - Lifetime
- 1994-05-09 DK DK94916061T patent/DK0698216T4/da active
- 1994-05-09 AT AT94916061T patent/ATE281647T1/de active
- 1994-11-09 US US08/336,553 patent/US6054264A/en not_active Expired - Lifetime
-
1995
- 1995-05-11 US US08/439,157 patent/US6416944B1/en not_active Expired - Lifetime
-
1999
- 1999-11-09 US US09/437,895 patent/US6416946B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK282543B6 (sk) | Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe | |
US7728121B2 (en) | Hepatitis-C virus type 4, 5 and 6 | |
FI113967B (fi) | Hepatitis-C-virustesti | |
JP2007197456A (ja) | Nanbvの診断用薬 | |
Chang et al. | Artificial NS4 mosaic antigen of hepatitis C virus | |
CA2162250C (en) | Methods of typing hepatitis c virus and reagents for use therein | |
CA2162134C (en) | Hepatitis-c virus type 4,5 and 6 | |
PT89041B (pt) | Metodo de preparacao de diagnosticos e vacinas nanbv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20140509 |